Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion

You'll see the newer oral anticoagulants (Pradaxa, Xarelto, Eliquis) used in patients with new onset atrial fib undergoing cardioversion.

We know that cardioversion sometimes converts patients back to normal heart rhythm. But it also increases the risk of stroke...if an atrial clot is dislodged during the procedure.

That's why anticoagulants are usually given in therapeutic doses for at least 3 weeks before cardioversion...to stabilize clots and decrease the risk of embolism.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote